在治疗癌症疼痛和过渡到幸存者的治疗中使用布普伦诺芬
Heather J Jackson1, Taylor Butler2, Bethany Raffalovich3
1Heather J. Jackson.
Clinical journal of oncology nursing
|September 23, 2025
概括
布普伦诺芬是一种部分片受体激动剂,为治疗癌症疼痛提供了一个独特的选择. 它有助于平衡患者舒适与治疗副作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 癌症疼痛管理在平衡疗效和副作用方面存在挑战.
- 类阿片类止痛药是基本的,但存在风险.
- 需要新的治疗策略来优化疼痛控制.
研究的目的:
- 评估布普伦诺芬作为癌症相关疼痛的治疗选择.
- 评估其在控制疼痛的有效性,同时最大限度地减少不良事件.
主要方法:
- 对癌症患者使用布普伦诺芬的临床数据的审查.
- 对药理动力学和药理动力学性质的分析.
- 与传统的阿片类药物疗法进行比较.
主要成果:
- 布普伦诺啡因表现出有利的副作用概况.
- 它的部分mu-阿片类受体激素可能会提供一个独特的治疗窗口.
- 临床结果表明,在精选的癌症群体中,有效缓解疼痛.
结论:
- 布普伦诺啡因代表了癌症疼痛管理的可行替代方案.
- 它独特的药理作用需要进一步研究,以优化患者护理.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
931
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
931
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Opioid Analgesics: Morphine and Other Natural Cogeners
865
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
865


